Ultralife Corp (NASDAQ:ULBI) shares, rose in value on Wednesday, June 18, with the stock price down by -2.29% to the previous day’s close as strong demand from buyers drove the stock to $8.11.
Actively observing the price movement in the last trading, the stock closed the session at $8.30, falling within a range of $8.01 and $8.37. The value of beta (5-year monthly) was 0.911 whereas the PE ratio was 25.74 over 12-month period. Referring to stock’s 52-week performance, its high was $12.40, and the low was $4.07. On the whole, ULBI has fluctuated by 44.56% over the past month.
With the market capitalization of Ultralife Corp currently standing at about $134.89 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-09.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 211.7M, with a low estimate of 51M and a high estimate of 51M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 51M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ULBI’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of ULBI currently trading nearly 13.53% and 41.81% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 70.29, while the 7-day volatility ratio is showing 3.27% which for the 30-day chart, stands at 4.45%. Furthermore, Ultralife Corp (ULBI)’s beta value is 0.91, and its average true range (ATR) is 0.42.
A comparison of Ultralife Corp (ULBI) with its peers suggests the former has fared considerably weaker in the market. ULBI showed an intraday change of -2.29% in last session, and over the past year, it shrunk by -20.02%%.
Data on historical trading for Ultralife Corp (NASDAQ:ULBI) indicates that the trading volumes over the past 10 days have averaged 0.15 and over the past 3 months, they’ve averaged 85.94K. According to company’s latest data on outstanding shares, there are 16.63 million shares outstanding.
Nearly 39.44% of Ultralife Corp’s shares belong to company insiders and institutional investors own 35.81% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.38 million shares as on 2025-05-30, resulting in a short ratio of 4.86. According to the data, the short interest in Ultralife Corp (ULBI) stood at 380.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.28 million. The stock has risen by 8.86% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ULBI stock heading into the next quarter.
